Exploring the riskreward balance in focal therapy for prostate cancera contribution to the debate
Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate
01:36 EST 22 Jan 2019 |
NEJM
More From BioPortfolio on "Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate"